You are here

Our science / Clinical Trials / Find a Trial / NCT00137410

Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee

Back to Search Print Save as PDF Bookmark Trial

NCT00137410

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Rutigliano, BA, 70018 Italy
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Osteoarthritis,Knee
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
50 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- diagnosis of OA of the knee according to the ACR Classification Criteria for
osteoarthritis;

- patients in flare

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- any concomitant inflammatory rheumatic condition which may interfere with the
assessment of OA

- clinical or radiological evidence of chondrocalcinosis

NCT00137410
Pfizer
Completed
Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now